EU approves Pfizer's axitinib and Takeda/NPS's teduglutide
This article was originally published in Scrip
Executive Summary
The EMA has approved new drugs from Pfizer (axitinib) and Takeda/NPS Pharmaceuticals (teduglutide) following their endorsement by the CHMP at its May and June meetings respectively.